John A Katzenellenbogen

This inventor holds 10 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: University of Illinois, University of California, Centre National De La Recherche Scientifique. Active years: 1977-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John A Katzenellenbogen. Retrieved from https://idiyas.com/inventor/john-a-katzenellenbogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 5)

% Patents Active = 70.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

9 out of 2,424

University of Illinois

patents

2 out of 16,008

University of California

patents

1 out of 5,383

Centre National De La Recherche Scientifique

International Minerals & Chemical Corp.

patents

6. 1 out of 618

Memorial Sloan Kettering Cancer Center

patents

7. 1 out of 184

Stevens Institute of Technology

patents

8. 1 out of 5,633

The University of Texas System

patents

9. 1 out of 186

Universitéde Strasbourg

patents

where one patent can have more than one assignee

Years Active: 1977-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286407 - Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases (2025-04-29),

2. 12187662 - FOXM1 inhibitor compositions and methods of using the same (2025-01-07),

3. 11673866 - Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases (2023-06-13),

4. 11667621 - Antiestrogen compounds (2023-06-06),

5. 10703698 - Compounds which activate estrogen receptors and compositions and methods of using the same (2020-07-07),

6. 9868705 - Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer (2018-01-16),

7. 9448173 - Dye-conjugated dendrimers (2016-09-20),

8. 9273115 - Method for controlling the biological activity of a protein in a vertebrate cell (2016-03-01),

9. 4851402 - Estriol growth promotant (1989-07-25),

10. 4064150 - Synthesis of isoprenoid 1,5-dienes (1977-12-20),

Title: John A. Katzenellenbogen: Pioneering Inventor from Urbana, IL

Introduction: John A. Katzenellenbogen is a renowned inventor hailing from Urbana, IL, known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: John A. Katzenellenbogen holds several patents in various industries, including biotechnology, pharmaceuticals, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over three decades, John A. Katzenellenbogen has established himself as a leading figure in the world of inventions, with numerous successful ventures and patents to his name.

Collaborations: Throughout his career, John A. Katzenellenbogen has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and excellence in all his projects.

Conclusion: John A. Katzenellenbogen's passion for innovation and relentless pursuit of excellence have solidified his position as a trailblazing inventor, inspiring generations to come in the realm of patents and inventions.

Profile summary based on public USPTO records.